Citigroup Maintains Buy on Accendra Health, Raises Price Target to $5

Benzinga Newsdesk www.benzinga.com Positive 79.1%

Neg 0% Neu 0% Pos 79.1%

Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and raises the price target from $3.25 to $5.